MANTLE CELL LYMPHOMA STAGE IV

This adverse event was reported 60 times

These drugs are most commonly taken by patients reporting MANTLE CELL LYMPHOMA STAGE IV:

# Drug Count
0 RITUXIMAB 20
1 CYCLOPHOSPHAMIDE 15
2 CYCLOPHOSPHAMIDE FOR INJECTION 15
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 15
4 IBRUTINIB 12
5 DOXORUBICIN 11
6 CYCLOSPORINE 10
7 ADALIMUMAB 9
8 URSODIOL 9
9 URSOSIOL 9
See all common drugs associated with MANTLE CELL LYMPHOMA STAGE IV

MANTLE CELL LYMPHOMA STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRIMIPRAMINE 1 0.0009
1 PIOGLITAZONE AND METFORMIN HYDROCHLORIDE 1 0.0008
2 MITOXANTRONE HYDROCHLORIDE 4 0.0006
3 BREXUCABTAGENE AUTOLEUCEL 1 0.0005
4 URSOSIOL 9 0.0005
5 CARMUSTINE 2 0.0004
6 URSODIOL 9 0.0004
7 GLOFITAMAB 1 0.0004
8 MELPHALAN HYDROCHLORIDE 7 0.0003
9 AMANTADINE HYDROCHLORIDE 1 0.0002
See all drugs enriched for association with MANTLE CELL LYMPHOMA STAGE IV